Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
04/2006
04/26/2006CN1762491A Use of BCG as adjuvant of active protein activating cytotoxic T-lymphocyte
04/26/2006CN1762484A Bolus for treating hepatitis A, hepatitis B, chronic hepatitis and preparation method thereof
04/26/2006CN1762480A Medicated leaven formulation and its preparation method
04/26/2006CN1762477A Chinese medicinal preparation for accelerating alcohol metabolism
04/26/2006CN1762474A Effervescence tablet for cold
04/26/2006CN1762461A Rhubarb lyophilized injection and preparation method thereof
04/26/2006CN1762455A Chinese medicinal formulation for treating infant lung and stomach exuberance heat
04/26/2006CN1762453A Essential oil of 'Shiquan Dabu Wan', namely beta-cyclodextrin inclusion compound and its preparation process
04/26/2006CN1762451A Constipation treating Chinese medicinal composition
04/26/2006CN1762425A Efervescence tablet with kudzuvine root, scutellarta root, Chinese goldthread and its preparation method
04/26/2006CN1762415A Astragalus root pills formula and its preparation method
04/26/2006CN1762398A Method for extracting ferula feruloides medicinal composition
04/26/2006CN1762394A Trogopterus dung-containing pain-relieving pill formula and its preparation method
04/26/2006CN1762393A Mongolian medicinal and edible powder for treating infants diarrhea and andropathy
04/26/2006CN1762392A Coriolus versicolor zymolyte, its preparation method and use for adjuvant as alcoholic drink
04/26/2006CN1762383A Preparation process of hepatic cell growth promotion protein and its injection preparation method
04/26/2006CN1762370A Polyene phosphatidyl choline lyophilized powdered injection
04/26/2006CN1762367A Ursodeoxycholic acid pills formula and its preparation method
04/26/2006CN1762351A Tinizadole dental plaster for treating buccal inflammation
04/26/2006CN1762347A Andrographolide preparation and its production method
04/26/2006CN1762345A Silybinin injection and its preparation method
04/26/2006CN1762344A Silybinin lyophilized formulation and its preparation method
04/26/2006CN1762343A EGCG-zinc complex solid dispersion, its preparation method and application
04/26/2006CN1762341A Salvianolic acid compound for treating cardiovascular and cerebrovascular disease and liver disease, and application thereof
04/26/2006CN1253452C Thioether subsituted imidazoquinoline compound
04/26/2006CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors
04/26/2006CN1253441C Protease inhibitors
04/26/2006CN1253437C Medicinal compound for curing disease of gastrointestinal tract, preparation method and relevant medication
04/26/2006CN1253435C Aryl oxime-piperazines useful as CCR5 antagonists
04/26/2006CN1253203C Proprietary Chinese traditional medicine for preventing and treating postpartum cow constitutional debility and retained afterbirth
04/26/2006CN1253196C Medicine for treating colitis
04/26/2006CN1253192C Medicine for treating summer heat wetness cold and preparing method
04/26/2006CN1253187C Chinese medicinal composition for preparing health caring medicinal wine
04/26/2006CN1253186C Primordial qi strengthening plaster
04/26/2006CN1253177C Medicine for treating bile backflow gastritis
04/26/2006CN1253174C Oral liquor for tonify kidney and invigorate yang
04/26/2006CN1253173C Inclusion active substance improved vitamin U belladonna and aluminium capsule II
04/26/2006CN1253170C Chinese medicine preparation for treating hepatitis and its preparing and detecting method
04/26/2006CN1253166C Medicine for treating gastric ulcer, chronic gastritis and dyspepsia
04/26/2006CN1253165C Ginseng and aconite quick release drop pill for treating qi vacuity and yang desertion and its preparation method
04/25/2006US7034176 Aminopropylphosphinic acids
04/25/2006US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease
04/25/2006US7034131 Antibody therapy; immobilization
04/25/2006US7034111 17867, a novel human aminopeptidase
04/25/2006US7034108 Mimotopes of hypervariable region 1 of the E2 glycoprotein of HCV and uses thereof
04/25/2006US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease
04/25/2006US7034048 Gastrin and cholecystokinin receptor ligands (III)
04/25/2006US7034043 Cell adhesion inhibitors
04/25/2006US7034038 Gastrointestinal disorders; antiulcer agents caused by Helicobacter
04/25/2006US7034034 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives
04/25/2006US7034031 Modulators of TNF-α signaling
04/25/2006US7034028 Treatment of inflammatory disorders
04/25/2006US7034027 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers
04/25/2006US7034025 Administering to a mammal an effective dose of a cysteine derivatives containing heteroaromatic group for the treatment of arterial tension, embryogenesis, oncogenesis, diabetes, cell proliferation, and other diseases
04/25/2006US7034022 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections
04/25/2006US7034018 Substituted pyrrole mannich bases to combat pain and allergic reactions
04/25/2006US7034016 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives
04/25/2006US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors
04/25/2006US7034006 Use of lipid conjugates in the treatment of disease
04/25/2006US7033794 Basolateral sorting signal and inhibitors thereof
04/25/2006US7033744 Method for proliferating a liver cell, a liver cell obtained thereby, and use thereof
04/25/2006CA2438097C Cannabinoids pharmaceutical formulations
04/25/2006CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds
04/20/2006WO2006041985A2 Thienopyridinone compounds and methods of treatment
04/20/2006WO2006041048A1 Liver regeneration/repair controlling agent
04/20/2006WO2006041019A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxy­phenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same
04/20/2006WO2006041015A1 Amino alcohol derivative, addition salt thereof and immunosuppressive agent
04/20/2006WO2006040485A2 Macromolecule obtained from a bifidobacterium culture and use thereof for the prevention and treatment of inflammatory rheumatisms
04/20/2006WO2006040338A1 Difluoro-substituted imidazopyridines
04/20/2006WO2006040047A2 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit)
04/20/2006WO2006005912A3 Use of botulinum toxin for the preparation of a medicament for the treatment of lithiasis of salivary gland, gall bladder, kidney, or pancreas
04/20/2006US20060084809 Compounds as PDE IV and TNF-inhibitors
04/20/2006US20060084803 Bicyclic pyridine and pyrimidine P38 kinase inhibitors
04/20/2006US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
04/20/2006US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
04/20/2006US20060084661 IL-8 receptor antagonists
04/20/2006US20060084653 Beta-sheet mimetics and composition and methods relating thereto
04/20/2006US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
04/20/2006US20060084641 IL-8 receptor antagonists
04/20/2006US20060084633 Formulations for treating or preventing mucositis
04/20/2006US20060084621 Compositions and methods for inhibiting expression of anti-apoptotic genes
04/20/2006US20060083792 Utilizing nanocrystalline silver metal, alloy or compound for localized tissue infections; reducing side effects; limiting overuse of antibiotics
04/20/2006US20060083790 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea
04/20/2006US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies
04/20/2006US20060083733 High-concentration preparation of soluble thrombomodulin
04/20/2006US20060083686 Therapeutic agent for ulcerative colitis
04/20/2006CA2583846A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrates thereof, and intermediates in the production thereof
04/20/2006CA2583353A1 Thienopyridinone compounds and methods of treatment
04/20/2006CA2583269A1 Macromolecule obtained from a bifidobacterium culture and use thereof for the prevention and treatment of inflammatory rheumatisms
04/20/2006CA2583253A1 Difluoro-substituted imidazopyridines
04/19/2006EP1647597A1 Chemokine N-terminal deletion mutations
04/19/2006EP1646656A2 Human antibody molecules for il-13
04/19/2006EP1646390A1 A1 adenosine receptor antagonists
04/19/2006EP1646384A1 Enema preparation
04/19/2006EP1556371B1 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor
04/19/2006EP1556140A4 Novel compounds
04/19/2006EP1448564B1 Substituted indolizine-like compounds and methods of use
04/19/2006EP1436005A4 Inhibition of neonatal hyperbilirubinemia in breast fed infants
04/19/2006EP1387838B1 Cyanoanthranilamide derivatives and the use thereof as medicaments
04/19/2006EP1373478B1 Attenuated live vaccine